Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease

被引:114
作者
Pannier, B
Guerin, AP
Marchais, SJ
Metivier, F
Safar, ME
London, GM
机构
[1] Hop Manhes, Serv Nephrol Hemodialyse, F-91712 Fleury Merogis, Ste Genevieve D, France
[2] Hop Broussais, Serv Med Interne, F-75674 Paris, France
关键词
cardiac hypertrophy; arteriosclerosis; endothelium; renal failure; hyperemia uremia;
D O I
10.1046/j.1523-1755.2000.00936.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Cardiovascular complications are the major cause of death in end-stage renal disease (ESRD) patients. These complications are associated with concomitant cardiac and vascular remodeling, including left ventricular (LV) hypertrophy and hypertrophy of arterial walls. The endothelium influences the process of arterial remodeling. ESRD patients are characterized by the development of both cardiovascular remodeling and endothelial dysfunction. Methods. Common carotid artery (CCA) intima-media thickness (IMT), CCA diameter, CCA distensibility, LV mass, and function were determined in 60 stable ESRD patients on hemodialysis and 34 age-, sex-, and blood pressure (BP)-matched controls, and their relationships with endothelial alterations were estimated by forearm postischemic vasodilation [flow debt repayment (FDR)] measured by venous plethysmography. We also evaluated th: relationships between FDR and several cardiovascular risk factors or markers of inflammatory response or endothelial activation, for example, duration of dialysis, BP, smoking habits, cholesterol, parathormone (PTH), serum albumin, plasma fibrinogen, C-reactive protein (CRP), plasma homocysteine, plasminogen activator inhibitor (PAI-1), and von Willebrand factor (VWF). Results. ESRD patients had increased LV mass, CCA diameter and CCA IMT, and had decreased CCA distensibility (P < 0.05). While the postischemic peak flow was comparable in controls and ESRD patients (29.2 +/- 9.1 vs. 27.9 +/- 0.2 mL/100 mL/min), FDR was lower in ESRD patients (116 +/- 31 vs. 88 +/- 32%, P < 0.001) because of the shorter duration of vasodilation (127 +/- 36 vs. 96 +/- 32 s, Pt 0.001). The time to complete FDR was longer in ESRD patients (110 +/- 54 vs. 162 +/- 72 s, P < 0.001). ESRD patients had lower high-density lipoprotein cholesterol and serum albumin (P < 0.01) and higher triglycerides fibrinogen, plasma homocysteine, vWF (P < 0.01), and PAI-1 (P < 0.05). For ESRD patients, significant negative age- and pressure-independent correlations were established between FDR and CCA diameter, duration of dialysis, and PAI-1. FDR was positively correlated with serum albumin. FDR and time to FDR were negatively correlated with CCA IMT and LV mass. CCA distensibility was positively associated with FDR (P < 0.001) and negatively with time to FDR (P < 0.001). The PAI 1 concentration was positively correlated with CCA IMT (P < 0.01) and negatively with CCA distensibility (P < 0.001). Conclusions. Our data provide the first evidence that cardiac and arterial remodeling in ESRD patients are inversely related to forearm reactive hyperemia. The diminished hyperemic response is due to the shorter duration of hyperemia and is associated with higher concentrations of serum markers of endothelial activation, suggesting that, in ESRD patients, endothelial dysfunction may be a factor influencing cardiovascular changes.
引用
收藏
页码:1091 / 1099
页数:9
相关论文
共 51 条
[1]   STUDIES OF THE VESSEL WALL PROPERTIES IN HEMODIALYSIS-PATIENTS [J].
BARENBROCK, M ;
SPIEKER, C ;
LASKE, V ;
HEIDENREICH, S ;
HOHAGE, H ;
BACHMANN, J ;
HOEKS, APG ;
RAHN, KH .
KIDNEY INTERNATIONAL, 1994, 45 (05) :1397-1400
[2]   Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease [J].
Blacher, J ;
Demuth, K ;
Guerin, AP ;
Safar, ME ;
Moatti, N ;
London, GM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (04) :535-541
[3]   PLASMA ANGIOTENSIN-CONVERTING ENZYME-ACTIVITY AND CAROTID WALL THICKENING [J].
BONITHONKOPP, C ;
DUCIMETIERE, P ;
TOUBOUL, PJ ;
FEVE, JM ;
BILLAUD, E ;
HERAUD, V .
CIRCULATION, 1994, 89 (03) :952-954
[4]   Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes [J].
Bostom, AG ;
Lathrop, L .
KIDNEY INTERNATIONAL, 1997, 52 (01) :10-20
[5]   ABNORMALITIES OF THE PERIPHERAL-CIRCULATION IN PATIENTS WITH CHRONIC RENAL-FAILURE [J].
BRADLEY, JR ;
EVANS, DB ;
COWLEY, AJ .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1988, 3 (04) :412-416
[6]   Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension [J].
Campese, VM ;
Tawadrous, M ;
Bigazzi, R ;
Bianchi, S ;
Mann, AS ;
Oparil, S ;
Raij, L .
HYPERTENSION, 1996, 28 (03) :335-340
[7]   LYSOPHOSPHATIDYLCHOLINE INHIBITS RELAXATION OF RABBIT ABDOMINAL-AORTA MEDIATED BY ENDOTHELIUM-DERIVED NITRIC-OXIDE AND ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR-INDEPENDENT OF PROTEIN-KINASE-C ACTIVATION [J].
COWAN, CL ;
STEFFEN, RP .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (12) :2290-2297
[8]  
DARAK N, 1998, HYPERTNSION, V32, P9
[9]   Endothelin and cardiovascular remodelling in end-stage renal disease [J].
Demuth, K ;
Blacher, J ;
Guerin, AP ;
Benoit, MO ;
Moatti, N ;
Safar, ME ;
London, GM .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (02) :375-383
[10]   ECHOCARDIOGRAPHIC DETERMINATION OF LEFT-VENTRICULAR MASS IN MAN - ANATOMIC VALIDATION OF METHOD [J].
DEVEREUX, RB ;
REICHEK, N .
CIRCULATION, 1977, 55 (04) :613-618